ANTIBAKTERIELLE MITTEL

Patent europeic · EP1395585 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1395585
Numer da la dumonda
EP02727861
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
01-05-2002
Publitgà
10-03-2004
Concedì
04-01-2006
Stritgà
04-01-2006
Motiv
Nagin effect per la Svizra ed il Liechtenstein
Classas IPC
C07D 471/04 (2006.01)
A61K 31/519 (2006.01)
A61P 31/04 (2006.01)
C07D 487/04 (2006.01)
//C07D 471/04 (2006.01)
//C07D 239/00 (2006.01)
//C07D 221/00 (2006.01)
Prioritad
US 294338 P 30.05.2001
US 365077 P 19.03.2002
Dumonda PCT
PCT/IB2002/001598 01.05.2002
Publicaziun PCT
WO2002/096908 05.12.2002
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-07-2006

    Midada

    Published in +pat+ No 13 in 2006

  2. 13-01-2006

    Concedì

    Published in +pat+ No 1 in 2006

Partidas

Inventur

ELLSWORTH, Edmund Lee, Pfizer Global R&D

Ann Arbor, MI 48105, US

SHOWALTER, Howard Daniel Hollis, Pfizer Global R&D

Ann Arbor, MI 48105, US

HUTCHINGS, Kim Marie, Pfizer Global R&D

Ann Arbor, MI 48105, US

NGUYEN, Dai, Quoc

Edmonton, Alberta T6L 6J9, CA

SINGH, Rajeshwar

Edmonton, Alberta T6R 2Y1, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.